[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-350541-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-350541-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","validation-of-the-taiwan-cancer-frailty-tool-for-screening-and-prognosis-in-non-older-patients-with-cancer-prospective-multicenter-study","Validation of the Taiwan Cancer Frailty Tool for Screening and Prognosis in Non-older Patients With Cancer - Prospective Multicenter Study","","Frailty is a recognized predictor of cancer outcomes in older adults, yet its identification in non-older populations remains limited. This prospective multicenter observational study compared the Taiwan Cancer Frailty Tool (TCFT) with the Flemish Triage Risk Screening Tool (fTRST) and comprehensive geriatric assessment (CGA) for frailty screening in Taiwanese patients aged under 65. Across 1,162 patients (2022–2024), TCFT showed higher sensitivity and stronger prognostic consistency across thresholds, supporting routine use.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/validation-of-the-taiwan-cancer-frailty-tool-for-screening-and-prognosis-in-non-older-patients-with-cancer-prospective-multicenter-study/350541/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/validation-of-the-taiwan-cancer-frailty-tool-for-screening-and-prognosis-in-non-older-patients-with-cancer-prospective-multicenter-study/350541.png","ImageObject",300,407,{"name":42,"@type":43},"Ben ","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-19","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",14,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the main goal of this study?","Question",{"text":63,"@type":64},"To validate whether the Taiwan Cancer Frailty Tool (TCFT) can screen frailty and predict prognosis in non-older Taiwanese patients with cancer, compared with fTRST and comprehensive geriatric assessment (CGA).","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was frailty defined for the reference standard?",{"text":68,"@type":64},"Frailty was assessed using CGA as the reference standard, with frailty defined as having at least 2 abnormal CGA domains.",{"name":70,"@type":61,"acceptedAnswer":71},"What diagnostic performance did TCFT show compared with fTRST?",{"text":72,"@type":64},"TCFT with the >0 threshold showed higher sensitivity and negative predictive value than fTRST >0, while TCFT >1 provided superior specificity and positive predictive value.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},350541,1790251498,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":113,"preview_page_count":33,"preview_urls":146},2336478951081,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Research Article  \n\n| Validation of the Taiwan Cancer Frailty Tool for Screening and Prognosis in Non-older Patients With Cancer: A Prospective Multicenter Study | Cancer Control Volume 33: 1–12 © The Author(s) 2026 Article reuse guidelines:\u003Cbr>[sagepub.com/journals-permissions](sagepub.com/journals-permissions)\u003Cbr>[DOI: 10.1177/10732748261466382](DOI: 10.1177/10732748261466382)\u003Cbr>[journals.sagepub.com/home/ccx](journals.sagepub.com/home/ccx)\u003Cbr>\u003Cbr>|\n| --- | --- |\n| Chia-Yen Hung, MD1,2, Yu-Shin Hung, MD1, and Wen-Chi Chou, MD, PhD1\u003Cbr>Abstract\u003Cbr>Introduction: Frailty is a known predictor of poor outcomes in older patients with cancer; however, its recognition in nonolder populations remains limited. In this prospective multicenter observational study, we compared the Taiwan Cancer Frailty Tool (TCFT) with the Flemish version of the Triage Risk Screening Tool (fTRST) and comprehensive geriatric assessment (CGA) in screening for frailty among non-older Taiwanese patients with cancer. Methods: We prospectively enrolled 1,162 patients with cancer aged \u003C65 years from multiple Taiwanese centers (2022–2024). Frailty was assessed using CGA (reference standard), TCFT, and fTRST, with frailty defined as ≥2 abnormal CGA domains. Both TCFT and fTRST were tested at two thresholds (>0 and >1) . Diagnostic performance metrics and Kaplan-Meier survival analyses were performed. Results: The median patient age was 54 years (range, 20–64 years), and 74.6% were male. The predominant cancer types were head and neck, esophageal, and gastric/small bowel cancers. The prevalence of frailty was 44.0%(CGA), 65.0%(TCFT >0), and 73.4%(fTRST >0). TCFT >0 demonstrated a higher sensitivity (88.8%) and negative predictive value (86.0%) than fTRST >0 (88.5% and 80.9%, respectively). TCFT >1 provided superior specificity (93.1%) and positive predictive value (83.5%). The area under the curve for TCFT was significantly higher than that for fTRST (0.788 vs. 0.748; p = 0.012). All tools predicted poor survival, with TCFT exhibiting a more consistent prognostic performance across thresholds than fTRST. Conclusion: Frailty is prevalent and prognostically significant in non-older patients with cancer. TCFT demonstrated superior diagnostic and prognostic utility compared with fTRST, supporting its integration into routine frailty screening for this population.\u003Cbr>Keywords\u003Cbr>frailty assessment, non-older, screening, validation, vulnerability Received: 30 January 2026; Revised: 14 April 2026; Accepted: 17 June 2026\u003Cbr>Introduction\u003Cbr>Frailty is increasingly recognized as a critical determinant of cancer treatment outcomes, influencing therapeutic tolerance, complication rates, and overall survival (OS) .1-3 Comprehensive geriatric assessment (CGA) is the gold standard for assessing frailty, encompassing domains such as functional status, nutrition, comorbidity, cognition, psychological health, |  |\n| 1Department of Hematology and Oncology, Chang Gung University, Chang Gung Memorial Hospital at Linkou and College of Medicine, Taoyuan, Taiwan 2Department of Hematology and Oncology, Mackay Memorial Hospital, Taipei, Taiwan\u003Cbr>Corresponding author:\u003Cbr>Wen-Chi Chou, MD, PhD, Department of Hematology and Oncology, Chang Gung Memorial Hospital, 5 Fu-Hsing Street, Kwei-Shan Shiang, Taoyuan, Taiwan. Email: [f12986@cgmh.org.tw](f12986@cgmh.org.tw) |  |\n\nCreative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons  \nAttribution-NonCommercial 4.0 License ([https://creativecommons.org/licenses/by-nc/4.0/](https://creativecommons.org/licenses/by-nc/4.0/)) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages ([https://us.sagepub.com/en-us/nam/open-access-at-sage](https://us.sagepub.com/en-us/nam/open-access-at-sage)).  \nand social support.4-6 Despite its comprehensiveness, CGA is time-intensive a","cbCaigZJi20JrHN3","https://ap.wps.com/l/cbCaigZJi20JrHN3","pdf",1739449,12,"English","# Abstract\n## Introduction\n## Methods\n## Results\n## Conclusion\n## Keywords","[{\"question\":\"What was the main goal of this study?\",\"answer\":\"To validate whether the Taiwan Cancer Frailty Tool (TCFT) can screen frailty and predict prognosis in non-older Taiwanese patients with cancer, compared with fTRST and comprehensive geriatric assessment (CGA).\"},{\"question\":\"How was frailty defined for the reference standard?\",\"answer\":\"Frailty was assessed using CGA as the reference standard, with frailty defined as having at least 2 abnormal CGA domains.\"},{\"question\":\"What diagnostic performance did TCFT show compared with fTRST?\",\"answer\":\"TCFT with the \\u003e0 threshold showed higher sensitivity and negative predictive value than fTRST \\u003e0, while TCFT \\u003e1 provided superior specificity and positive predictive value.\"}]","Validation of the Taiwan Cancer Frailty Tool for Screening and Prognosis in Non-older Patients With Cancer - Prospective Multicenter Study | PDF",1790089491,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c17ec7f811e6a5249adf619b8caade08.webp",983,1310,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/36b16c39eb2a6f5709e7fc51365bcff0.webp",982,1309,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a65c2596404f7888ddcfe03c6c19fb78.webp",981,1308,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/91592488e84f494128e6172050a3c5a5.webp",980,1306]